Spruce Biosciences (SPRB)

• Market cap: $64.2M
• 1 day: 2.16%
• 5 days: 13.64%
• 1 month: -27.44%
• 3 months: -45.45%
• 6 months: 512.24%
• Year to date: -33.85%
• 1 year: 103.8%
• 5 years: -96.17%
• 10 years: -95.29%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20